Completed
Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
NCT03813940
- Conditions
- Cervical Cancer, Communicable Diseases, Condylomata Acuminata, +28 more
- Locations
-
- Jiangsu Provincial Centre for Disease Control and Prevention Nanjing, Jiangsu, China